Core Viewpoint - Haicheng Bangda Supply Chain Management Co., Ltd. is facing a challenging financial situation with declining revenue and net profit, alongside low profit margins compared to industry averages [2][9]. Group 1: Financial Performance - For the first three quarters of this year, the company's revenue was approximately 6.529 billion yuan, a year-on-year decline of 13.74% [9]. - The net profit attributable to shareholders was 34 million yuan, down 59.15% year-on-year, while the net profit after deducting non-recurring items was 21 million yuan, a decrease of 73.37% [9]. - The gross margin stood at 6.33%, and the net margin was 0.48%, significantly lower than the industry median values of 12.96% and 3.88% respectively [2][9]. Group 2: Capital Actions - As of the end of October, the company had repurchased shares worth 40.1079 million yuan, acquiring 2,929,900 shares, which is 1.43% of the total share capital [3]. - The company plans to repurchase shares using 40 million to 80 million yuan of its own funds and loans, with a maximum repurchase price adjusted to 16.85 yuan per share [3]. - The company redeemed 110 million yuan of idle raised funds, recovering the principal and earning 536,300 yuan in interest from a structured deposit [3][4]. Group 3: Cash Management - The company has utilized 885 million yuan for cash management over the past 12 months, recovering 685 million yuan and earning a total of 2.9474 million yuan in returns [4]. - As of September 30, the cash balance was 963 million yuan, with the recent investment in financial products amounting to 150 million yuan, representing 15.58% of the latest cash balance [5]. Group 4: Project Progress - Since its IPO in 2021, only one of the three committed projects has been completed, with the remaining projects showing low investment progress [6]. - The "Logistics Network Expansion and Upgrade Project" has only progressed by 15.53%, while the "Supply Chain Information Technology Construction Project" has reached 24.81% [6][7]. - Adjustments have been made to the project timelines and investment structures to better align with business realities and external factors [7][8]. Group 5: Management Changes - A board member, Wang Xiping, plans to reduce his holdings by up to 198,400 shares, citing personal financial needs [8].

8月25日，塞力医疗盘中9.99%涨停，截至09:40，报34.24元/股，成交7.02亿元，换手率11.0%，总市值 65.4亿元。 来源：金融界 资料显示，塞力斯医疗科技集团股份有限公司位于武汉市东西湖区金山大道1310号，塞力斯医疗科技集 团主要业务在医疗集约化运营管理服务领域，与国内外知名IVD供应商建立合作关系，提供全面的体外 诊断产品供应链服务，并进一步发展信息化技术以支持集约化运营服务平台的建设。公司在供应链信息 化、区块链、物联网等信息技术领域有深度布局，并与大数据及信息管理系统平台开发公司保持紧密合 作。 截至3月31日，塞力医疗股东户数4.66万，人均流通股4099股。 2025年1月-3月，塞力医疗实现营业收入2.87亿元，同比减少40.75%；归属净利润-1432.09万元，同比减 少553.66%。 ...

8月22日，塞力医疗盘中10.02%涨停，截至14:17，报31.52元/股，成交15.19亿元，换手率26.46%，总市 值60.21亿元。 资料显示，塞力斯医疗科技集团股份有限公司位于武汉市东西湖区金山大道1310号，塞力斯医疗科技集 团主要业务在医疗集约化运营管理服务领域，与国内外知名IVD供应商建立合作关系，提供全面的体外 诊断产品供应链服务，并进一步发展信息化技术以支持集约化运营服务平台的建设。公司在供应链信息 化、区块链、物联网等信息技术领域有深度布局，并与大数据及信息管理系统平台开发公司保持紧密合 作。 来源：金融界 截至3月31日，塞力医疗股东户数4.66万，人均流通股4099股。 2025年1月-3月，塞力医疗实现营业收入2.87亿元，同比减少40.75%；归属净利润-1432.09万元，同比减 少553.66%。 ...

8月19日，塞力医疗盘中10.01%涨停，截至09:51，报32.86元/股，成交9.05亿元，换手率14.85%，总市 值62.77亿元。 资料显示，塞力斯医疗科技集团股份有限公司位于武汉市东西湖区金山大道1310号，塞力斯医疗科技集 团主要业务在医疗集约化运营管理服务领域，与国内外知名IVD供应商建立合作关系，提供全面的体外 诊断产品供应链服务，并进一步发展信息化技术以支持集约化运营服务平台的建设。公司在供应链信息 化、区块链、物联网等信息技术领域有深度布局，并与大数据及信息管理系统平台开发公司保持紧密合 作。 截至3月31日，塞力医疗股东户数4.66万，人均流通股4099股。 2025年1月-3月，塞力医疗实现营业收入2.87亿元，同比减少40.75%；归属净利润-1432.09万元，同比减 少553.66%。 来源：金融界 ...

8月1日，塞力医疗盘中上涨5.13%，截至09:40，报31.56元/股，成交2.82亿元，换手率4.77%，总市值 60.29亿元。 2025年1月-3月，塞力医疗实现营业收入2.87亿元，同比减少40.75%；归属净利润-1432.09万元，同比减 少553.66%。 资料显示，塞力斯医疗科技集团股份有限公司位于武汉市东西湖区金山大道1310号，塞力斯医疗科技集 团主要业务在医疗集约化运营管理服务领域，与国内外知名IVD供应商建立合作关系，提供全面的体外 诊断产品供应链服务，并进一步发展信息化技术以支持集约化运营服务平台的建设。公司在供应链信息 化、区块链、物联网等信息技术领域有深度布局，并与大数据及信息管理系统平台开发公司保持紧密合 作。 截至3月31日，塞力医疗股东户数4.66万，人均流通股4099股。 ...